Comparison of the carcinogenic potential of streptozotocin by polarography and alkaline elution

Neoplasma

Volumn 50, Issue 2, 2003, Pages 110-116

  Cojocel, C ^a   Novotny, L ^a   Vachalkova, A ^b   Knauf, B ^c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Alkaline elution; Carcinogenicity; Polarography; Single stranded DNA; Streptozotocin

Indexed keywords

METHYLNITROSOUREA; SINGLE STRANDED DNA; STREPTOZOCIN; THIOCTIC ACID;

ARTICLE; CARCINOGENIC ACTIVITY; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG EXPOSURE; ELECTRIC POTENTIAL; ELECTROCHEMICAL ANALYSIS; ELUTION; HUMAN; HUMAN CELL; LUNG TUMOR; METABOLISM; POLAROGRAPHY; PREDICTION; REDUCTION; TUMOR CELL; WORLD HEALTH ORGANIZATION;

EID: 0037653273     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. AGARWAL MK. Streptozotocin: mechanisms of action: proceedings of a workshop held on 21 June 1980, Washington, D.C. FEBS Lett 1980; 120: 1-3.
2. ANDERSSON AK, SANDLER S. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells. J Pineal Res 2001; 30: 157-165.
3. CHEN H, CARLSON EC, PELLET L, MORITZ JT, EPSTEIN PN. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 2001; 50: 2040-2046.
4. DUHAULT J, KOENIG-BERARD E. Diabetes mellitus and its animal models. Therapie 1997; 52: 375-384.
5. EIZIRIK DL, SPENCER P, KISBY GE. Potential role of environmental genotoxic agents in diabetes mellitus and neurodegenerative diseases. Biochem Pharmacol 1996; 51: 1585-1591.
6. GIARD DJ, AARONSON SA, TODARO GJ, AMSTEIN P, KERSEY JH, DOSIK H, PARKS WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Nad Cancer Inst 1973; 51: 1417-1423.
7. HASSAN N, JANJUA MZ. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat. J Ayub Med Coll Abbottabad 2001; 13: 26-30.
8. HINEGARDNER RT. An improved fluorometric assay for DNA. Anal Biochem 1971; 39: 197-201.
9. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. 1974; 4: 221-231.
10. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Some N-nitroso compounds. 1978; 17: 337-339.
11. KIUCHI K, YOSHIZAWA K, SHIKATA N, MATSUMURA M, TSUBURA A. Nicotinamide prevents N-methy-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats and C57BL mice. Exp Eye Res 2002; 74: 383-392.
12. KOHN KW, ERICKSON LC, EWIG RAG, FRIEDMAN CA. Fractionation of DNA from mammalian cells by alkaline elution. Biochemistry 1976; 15: 4629-4637.
13. LEDOUX SP, HALL CR, FORBES PM, PATTON NJ, WILSON GL. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozotocin toxicity. Diabetes 1998; 37: 1015-1019.
14. LEDOUX SP, WOODLEY SE, PATTON NJ, WILSON GL. Mechanisms of nitrosourea-induced beta-cell damage. Diabetes 1986; 35: 866-872.
15. MARON DM, AMES BN. Revised methods for the Salmonella mutagenicity test. Mutation Res 1983; 113: 173-215.
16. MARTIN CN, MCDERMID AC, GARNER RC. Testing of known carcinogens and noncarcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells. Cancer Res 1978; 38: 2621-2627.
17. MASIELLO P, NOVELLI M, FIERABRACCI V, BERGAMINI E. Protection by 3-amino-benzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro. Res Commun Chem Pathol Pharmacol 1990; 69: 17-32.
18. MITCHELL AD, CASCIANO DA, MELLZ ML, ROBINSON DE, SAN RHC, WILLIAMS GM, VON HALLE ES. Unscheduled DNA synthesis test: a report of the U.S. Environmental Protection Agency Gene Tox Program. Mutation Res 1983; 123: 363-410.
19. MURATA MA, TAKAHASHI A, SAITO I, KAWANISHI S. Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem Pharmacol 1999; 57: 881-887.
20. NOVOTNY L, VACHALKOVA A. Some electrochemical characteristics of synthetic analogs of nucleic acid components. I. Derivates of cytidine and arabinosylcytosine. An attempt to find correlation among some of their properties. Neoplasma 1990; 37:377-386.
21. OECD Guideline for Testing of Chemical Genetic Toxicology. DNA damage and repair/unscheduled DNA synthesis in mammalian cells in vitro. 1986; 482: 1-6.
22. PERSSON HL, SVENSSON AI, BRUNK UT. Alpha-lipoic acid and alpha-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis. Redox Rep 2001; 6: 327-334.
23. PETREPHER CC, LEDOUX SP, BOHR VA, WILSON GL. Repair of alkali-labile sites within the mitochondrial DNA of RINr38 cells after exposure to nitrosurea streptozotocin. J Biol Chem 1991; 266: 3113-3117.
24. PIEPER AA, BRAT DJ, KRUG DK, WATKINS CC, GUPTA A, BLACKSHAW S, VERMA A, WANG ZO, SYNER SH. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999; 96:3059-3064.
25. RERUP CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970; 22: 485-518.
26. RIDICK JA, BUNGER WB. N,N-dimethylformamid. In: Weissberger A, editor. Organic solvents, Vol. II. Wiley-Interscience, New York, 1970: 836-840.
27. SAINI KS, THOMPSON C, WINTERFORD CM, WALKER NI, CAMERON DP. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem Mol Biol Int 1996; 39: 1229-1236.
28. SANDLER S, SWENNE I. Effects of streptozotocin exposure in vitro on the replication and repair of DNA in fetal rat pancreatic islets cells. Pancreas 1989; 4: 53-58.
29. SCHACTERLE GR, POLLACK RL. A simplified method for quantitative assay of small amounts of protein in biologic material. Anal Biochem 1973; 51: 654-655.
30. 2 as mediator of DNA fragmentation. Diabetes 1991; 40: 1141-1145.
31. TYSON CK, MIRSALIS JC. Measurement of unscheduled DNA synthesis in rat kidney cells following in vivo treatment with genotoxic agents. Environ Mutagen 1985; 7: 889-899.
32. VACHALKOVA A, NOVOTNY L. Polarographic testing of carcinogenicity of some chemotherapeutics. Neoplasma 1997; 44: 389-394.
33. VURAL HT, SABUNCU T, ARSLAN SO, ASKOY N. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J Pineal Res 2001; 31: 193-198.